The contributions of disease and genetic factors towards regional cortical thinning in schizophrenia: The UCLA family study

Schizophrenia Research

Volumn 123, Issue 2-3, 2010, Pages 116-125

  Yang, Yaling ^a,b   Nuechterlein, Keith H ^b,c   Phillips, Owen ^a   Hamilton, Liberty S ^a   Subotnik, Kenneth L ^c   Asarnow, Robert F ^b,c   Toga, Arthur W ^a   Narr, Katherine L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cortical thickness; MRI; Relatives; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BRAIN MAPPING; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL THICKNESS; CORTICAL THINNING; FAMILY STUDY; FEMALE; FRONTAL CORTEX; GRAY MATTER; HEREDITY; HIGH RISK POPULATION; HUMAN; IMAGE ANALYSIS; MALE; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PRIORITY JOURNAL; RELATIVE; SCHIZOPHRENIA; SUBICULUM; TEMPORAL CORTEX; TEMPORAL LOBE;

ADULT; AGE OF ONSET; AGED; CALIFORNIA; CEREBRAL CORTEX; FAMILY; FEMALE; FRONTAL LOBE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OCCIPITAL LOBE; SCHIZOPHRENIA; TEMPORAL LOBE; UNIVERSITIES; YOUNG ADULT;

EID: 77957917228     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.08.005     Document Type: Article

References (72)

1. Anderson M.J., Braak C.J. Permutation tests for multi-factorial analysis of variance. J. Statist. Comput. Simul. 2003, 73:85-113.
2. Anderson M.J., Legendre P. An empirical comparison of permutation methods for tests of partial regression coefficients in a linear model. J. Statist. Comput. Simul. 1999, 62:271-303.
3. Asarnow R.F., Nuechterlein K.H., Fogelson D.L., Subotnik K.L., Payne D.L., Russell D., Asamen J., Kuppinger H., Kendler K.S. Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study. Arch. Gen. Psychiatry 2000, 58(6):581-588.
4. Asarnow R.F., Nuechterlein K.H., Fogelson D., Subotnik K.L., Payne D.A., Russell A.T., Asamen J., Kuppinger H., Kendler K.S. Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study. Arch. Gen. Psychiatry 2001, 58(6):581-588.
5. Boos H.B., Aleman A., Cohn W., Hulshoff Pol H., Kahn R.S. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch. Gen. Psychiatry 2007, 64(3):297-304.
6. Burger G.K., Calsyn R.J., Morse G.A., Klinkenberg W.D., Trusty M.L. Factor structure of the expanded Brief Psychiatric Rating Scale. J. Clin. Psychol. 1997, 53(5):451-454.
7. Cahn W., Hulshoff Pol H.E., Bongers M., Schnack H.G., Mandl R.C., Van Haren N.E., Durston S., Honing H., Van Der Linden J.A., Kahn R.S. Brain morphology in antipsychotic-naïve schizophrenia: a study of multiple brain structures. Br. J. Psychiatry Suppl. 2002, 43:s66-s72.
8. Cahn W., van Haren N.E.M., Hulshoff Pol H.E., Schnack H.G., Caspers E., Laponder D.A.J., Kahn R.S. Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. Br. J. Psychiatry 2006, 189:381-382.
9. Cannon T.D., van Erp T.G., Huttunen M., Lönnqvist J., Salonen O., Valanne L., Poutanen V.P., Standertskjöld-Nordenstam C.G., Gur R.E., Yan M. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch. Gen. Psychiatry 1998, 55(12):1084-1091.
10. Cardno A.G., Marshall E.J., Cold B., MacDonald A.M., Ribchester T.R., Davies N.J., Venturi P., Jones L.A., Lewis S.W., Sham P.C., Gottesman I.I., Farmer A.E., McGuffin P., Reveley A.M., Murray R.M. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch. Gen. Psychiatry 1999, 56(2):162-168.
11. Diwadkar V.A., Montrose D.M., Dworakowski D., Sweeney J.A., Keshavan M.S. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia?. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:230-238.
12. Eichenbaum H., Cohen N.J. From Conditioning to Conscious Recollection: Memory Systems of the Brain 2001, Oxford Univ., Upper Saddle River, NJ.
13. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., Benjamin L. Structured clinical interview for DSM-IV Axis II, Personality Disorders 1996, Biometrics Research Department, NewYork State Psychiatric Institute, New York.
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV Axis I Disorders-Patient edition 1997, In Biometrics Research Department, New York State Psychiatric Institute, New York.
15. Fogelson D.L., Nuechterlein K.H., Asarnow R.F., Subotnik K.L., Talovic S.A. Interrater reliability of the structured clinical interview for DSM-III-R, Axis II: schizophrenia spectrum and affective spectrum disorders. Psychiatry Res. 1991, 39(1):55-63.
16. Fogelson D.L., Nuechterlein K.H., Asarnow R.A., Payne D.L., Subotnik K.L., Jacobson K.C., Neale M.C., Kendler K.S. Avoidant personality disorder is a separable schizophrenia-spectrum personality disorder even when controlling for the presence of paranoid and schizotypal personality disorders The UCLA family study. Schizophr. Res. 2007, 91(1-3):192-199.
17. Fujioka M., Okuchi K., Hiramatsu K., Sakaki T., Sakaguchi S., Ishii Y. Specific changes in human brain after hypoglycemic injury. Stroke 1997, 28(3):584-587.
18. Goghari V.M., Rehm K., Carter C.S., MacDonald A.W. Regionally specific cortical thinning and gray matter abnormalities in the healthy relatives of schizophrenia patients. Cereb. Cortex 2007, 17(2):415-424.
19. Goghari V.M., Rehm K., Carter C.S., MacDonald A.W. Sulcal thickness as a vulnerability indicator for schizophrenia. Br. J. Psychiatry 2007, 191:229-233.
20. Goldberg T.E., Torrey E.F., Gold J.M., Bigelow L.B., Ragland R.D., Taylor E., Weinberger D.R. Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder. Schizophr. Res. 1995, 17(1):77-84.
21. Goldman A.L., Pezawas L., Mattay V.S., Fischl B., Verchinski B.A., Chen Q., Weinberger D.R., Meyer-Lindenberg A. Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. Arch. Gen. Psychiatry 2009, 66(5):467-477.
22. Green M.F., Nuechterlein K.H., Breitmeyer B., Mintz J. Forward and backward visual masking in unaffected siblings of schizophrenia patients. Biol. Psychiatry 2006, 59(5):446-451.
23. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999, 122(Pt 4):593-624.
24. Highley J.R., DeLisi L.E., Roberts N., Webb J.A., Relja M., Razi K., Crow T.J. Sex-dependent effects of schizophrenia: an MRI study of gyral folding, and cortical and white matter volume. Psychiatry Res. Neuroimaging 2003, 124(1):11-23.
25. Honea R.A., Meyer-Lindenberg A., Hobbs K.B., Pezawas L., Mattay V.S., Egan M.F., Verchinski B., Passingham R.E., Weinberger D.R., Callicott J.H. Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biol. Psychiatry 2008, 63:465-474.
26. Job D.E., Whalley H.C., McConnell S., Glabus M., Johnstone E.C., Lawrie S.M. Structural gray matter differences between first-episode schizophrenics and normal controls on voxel-based morphometry. Neuroimage 2002, 17:880-889.
27. Katz H., Davies C., Dobbing J. Effects of undernutrition at different ages early in life and later environmental complexity on parameters of the cerebrum and hippocampus in rats. J. Nutr. 1982, 112(7):1362-1368.
28. Kendler K.S. The super-normal control group in psychiatric genetics: possible artifactual evidence for co-aggregation. Psychiatr. Genet. 1990, 1:45-53.
29. Kéri S., Kelemen O., Janka Z., Benedek G. Visual-perceptual dysfunctions are possible endophenotypes of schizophrenia: evidence from the psychophysical investigation of magnocellular and parvocellular pathways. Neuropsychology 2005, 19(5):649-656.
30. Kuperberg G.R., Broome M.R., McGuire P.K., David A.S., Eddy M., Ozawa F., Goff D., West W.C., Williams S.C., van der Kouwe A.J., Salat D.H., Dale A.M., Fischl B. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch. Gen. Psychiatry 2003, 60(9):878-888.
31. Lawrie S.M. Premorbid structural abnormalities in schizophrenia. Neurodevelopment and Schizophrenia 2004, 347-372. Cambridge University Press, Cambridge, UK. M. Keshavan, J. Kennedy, R. Murray (Eds.).
32. Lawrie S.M., Abukmeil S.S. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br. J. Psychiatry 1998, 172:110-120.
33. Lawrie S.M., McIntosh A.M., Hall J., Owens D.G., Johnstone E.C. Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. Schizophr. Bull. 2008, 34(2):330-340.
34. Lenroot R.K., Schmitt J.E., Ordaz S.J., Wallace G.L., Neale M.C., Lerch J.P., Kendler K.S., Evans A.C., Giedd J.N. Differences in genetic and environmental influences on the human cerebral cortex associated with development during childhood and adolescence. Hum. Brain Mapp. 2009, 30(1):163-174.
35. Lieberman J.A., Stroup T.S., McEvoy J.P., Sawartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., Severe J., Hsiao J.K. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 2005, 353(12):1209-1223. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators.
36. Lim K.O., Sullivan E.V., Zipursky R.B., Pfefferbaum A. Cortical gray matter volume deficits in schizophrenia: a replication. Schizophr. Res. 1996, 20(1-2):157-164.
37. McIntosh A.M., Job D.E., Moorhead W.J., Harrison L.K., Whalley H.C., Johnstone E.C., Lawrie S.M. Genetic liability to schizophrenia or bipolar disorder and its relationship to brain structure. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141(1):76-83.
38. Miller G.A., Chapman J.P. Misunderstanding analysis of covariance. J. Abnorm. Psychol. 2001, 110(1):40-48.
39. Mitelman S.A., Brickman A.M., Shihabuddin L., Newmark R.E., Hazlett E.A., Haznedar M.M., Buchsbaum M.S. A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage 2007, 37(2):449-462.
40. Narayan V.M., Narr K.L., Kumari V., Woods R.P., Thompson P.M., Toga A.W., Sharma T. Regional cortical thinning in subjects with violent antisocial personality disorder or schizophrenia. Am. J. Psychiatry 2007, 164(9):1418-1427.
41. Narr K.L., van Erp T.G., Cannon T.D., Woods R.P., Thompson P.M., Jang S., Blanton R., Poutanen V.P., Huttunen M., Lonnqvist J., Standerksjold-Nordenstam C.G., Kaprio J., Mazziotta J.C., Toga A.W. A twin study of genetic contributions to hippocampal morphology in schizophrenia. Neurobiol. Dis. 2002, 11(1):83-95.
42. Narr K.L., Bilder R.M., Toga A.W., Woods R.P., Szeszko P.R., Robinson D., Sevy S., Gunduz-Bruce H., Wang Y.P., DeLuca H., Thompson P.M. Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb. Cortex 2005, 15(6):708-719.
43. Narr K.L., Toga A.W., Szeszko P., Thompson P.M., Woods R.P., Robinson D., Sevy S., Wang Y., Schrock K., Bilder R.M. Cortical thinning in cingulate and occipital cortices in first episode schizophrenia. Biol. Psychiatry 2005, 58(1):32-40.
44. Narr K.L., Builder R.M., Woods R.P., Thompson P.M., Szeszko P., Robinson D., Ballmaier M., Messenger B., Wang Y., Toga A.W. Regional specificity of cerebrospinal fluid abnormalities in first episode schizophrenia. Psychiatry Res. 2006, 146(1):21-33.
45. Narr K.L., Hageman N., Woods R.P., Hamilton L.S., Clark K., Phillips O., Shattuck D.W., Asarnow R.F., Toga A.W., Nuechterlein K.H. Mean diffusivity: a biomarker for CSF-related disease and genetic liability effects in schizophrenia. Psychiatry Res. 2009, 171(1):20-32.
46. Nelson M.D., Saykin A.J., Flashman L.A., Riordan H.J. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch. Gen. Psychiatry 1998, 55(5):433-440.
47. Nesvåg R., Lawyer G., Vernäs K., Fjell A.M., Walhovd K.B., Frigessi A., Jönsson E.G., Agartz I. Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age, and antipsychotic medication. Schizophr. Res. 2008, 98(1-3):16-28.
48. Nuechterlein K.H., Dawson M.E., Gitlin M.J., Ventura J., Goldstein M.J., Snyder K.S., Yee C.M., Mintz J. Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophr. Bull. 1992, 18(3):387-425.
49. Nuechterlein K.H., Asarnow R.F., Subotnik K.L., Fogelson D.L., Payne D.L., Kendler K.S., Neale M.C., Jacobson K.C., Mintz J. The structure of schizotypy: relationships between neurocognitive and personality disorder features in relatives of schizophrenic patients in the UCLA Family Study. Schizophr. Res. 2002, 54(1-2):121-130.
50. Pearlson G.D. Superior temporal gyrus and planum temporale in schizophrenia: a selective review. Prog. Neuropsychopharmacol. Biol. Psychiatry 1997, 21(8):1203-1229.
51. Saykin A.J., Gur R.C., Gur R.E., Mozley P.D., Mozley L.H., Resnick S.M., Kester D.B., Stafiniak P. Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch. Gen. Psychiatry 1991, 48(7):618-624.
52. Schmidt-Kastner R., Freund T.F. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 1991, 40(3):599-636.
53. Seidman L.J., Faraone S.V., Goldstein J.M., Kremen W.S., Horton N.J., Makris N., Toomey R., Kennedy D., Caviness V.S., Tsuang M.T. Left hippocampal volume as a volumerability indicator for schizophrenia: a magnetic resonance imaging morphometric study of nonpsychotic first-degree relatives. Arch. Gen. Psychiatry 2002, 59(9):839-849.
54. Selemon L.D., Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 1999, 45(1):17-25.
55. Shattuck D.W., Mirza M., Adisetiyo V., Hojatkashani C., Salamon G., Narr K.L., Poldrack R.A., Bilder R.M., Toga A.W. Construction of a 3D probabilistic atlas of human cortical structures. Neuroimage 2008, 39(3):1064-1080.
56. Shenton M.E., Dickey C.C., Frumin M., McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 2001, 49(1-2):1-52.
57. Sowell E.R., Peterson B.S., Thompson P.M., Welcome S.E., Henkenius A.L., Toga A.W. Mapping cortical change across the human life span. Nat. Neurosci. 2003, 6(3):309-315.
58. Sowell E.R., Thompson P.M., Leonard C.M., Welcome S.E., Kan E., Toga A.W. Longitudinal mapping of cortical thickness and brain growth in normal children. J. Neurosci. 2004, 24(38):8223-8231.
59. Staal W.G., Hulshoff Pol H.E., Schnack H.G., Hoogendoorn M.L., Jellema K., Kahn R.S. Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am. J. Psychiatry 2000, 157:416-421.
60. Stark A.K., Uylings H.B., Sanz-Arigita E., Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am. J. Psychiatry 2004, 161(5):882-888.
61. Steen R.G., Mull C., McClure R., Hamer R.M., Lieberman J.A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry 2006, 188:510-518.
62. Stevens G., Cho J.H. Socioeconomic indexes and the new 1980 Census occupational scheme. Soc. Sci. Res. 1985, 14:142-168.
63. Taylor J.L., Blanton R.E., Levitt J.G., Caplan R., Nobel D., Toga A.W. Superior temporal gyrus differences in childhood-onset schizophrenia. Schizophr. Res. 2005, 73(2-3):235-241.
64. Thompson P.M., Cannon T.D., Narr K.L., van Erp T., Poutanen V.P., Huttunen M., Lönngvist J., Standertskjöld-Nordenstam C.G., Kaprio J., Khaledy M., Dail R., Zoumalan C.I., Toga A.W. Genetic influences on brain structure. Nat. Neurosci. 2001, 4(12):1253-1258.
65. Thompson P.M., Bartzokis G., Hayashi K.M., Klunder A.D., Lu P.H., Edwards N., Hong M.S., Yu M., Geega J.A., Toga A.W., Charles C., Perkins D.O., McEvoy J., Hamer R.M., Tohen M., Tollefson G.D., Lieberman J.A. Time-lapse mapping of cortical changes in schizophrenia with different treatments. Cereb. Cortex 2009, 19(5):1107-1123. HGDH Study Group.
66. Ventura J., Liberman R.P., Green M.F., Shaner A., Mintz J. Training and quality assurance with the structured clinical interview for DSM-IV (SCID-I/P). Psychiatry Res. 1998, 79:163-173.
67. Ventura J., Nuechterlein K.H., Subotnik K.L., Gutkind D., Gilbert E.A. Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Res. 2000, 97(2-3):129-135.
68. Weinberger D.R. Schizophrenia and the frontal lobe. Trends Neurosci. 1988, 11(8):367-370.
69. Wright I.C., Rabe-Hesketh S., Woodruff P.W., David A.S., Murray R.M., Bullmore E.T. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry 2000, 157(1):16-25.
70. Wright I.C., Sham P., Murray R.M., Weinberger D.R., Bullmore E.T. Genetic contributions to regional variability in human brain structure: methods and preliminary results. Neuroimage 2002, 17(1):256-271.
71. Yang Y., Raine A., Colletti P., Toga A.W., Narr K.L. Abnormal temporal and prefrontal cortical gray matter thinning in psychopaths. Mol. Psychiatry 2009, 14(6):561-562.
72. Zipursky R.B., Lim K.O., Sullivan E.V., Brown B.W., Pfefferbaum A. Widespread cerebral gray matter volume deficits in schizophrenia. Arch. Gen. Psychiatry 1992, 49(3):195-205.